T cell gene therapy (Cell Genesys)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameT cell gene therapy (Cell Genesys)

Drug Alias NameAnti-HIV T cell gene therapy

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapyCell and gene therapy > Gene therapy

Mechanisms of ActionCluster of differentiation 8 stimulantsT-cell surface antigen CD4 agonists

TargetsT-cell surface antigen CD4Cluster of differentiation 8

Therapy Area/IndicationsColorectal NeoplasmsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesBiosante Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesBiosante Pharmaceuticals Inc

Active IndicationsN/A

Inactive IndicationsColorectal NeoplasmsHIV Infections

Other Information

ATC CodeN/A